These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17607331)

  • 1. Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians.
    Koponen H; Allgulander C; Erickson J; Dunayevich E; Pritchett Y; Detke MJ; Ball SG; Russell JM
    Prim Care Companion J Clin Psychiatry; 2007; 9(2):100-7. PubMed ID: 17607331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine in the treatment of generalized anxiety disorder.
    Wright A; Vandenberg C
    Int J Gen Med; 2009 Dec; 2():153-62. PubMed ID: 20360899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of falls in older patients treated with duloxetine: a secondary analysis of a 24-week randomized, placebo-controlled trial.
    Nelson JC; Oakes TM; Liu P; Ahl J; Bangs ME; Raskin J; Perahia DG; Robinson MJ
    Prim Care Companion CNS Disord; 2013; 15(1):. PubMed ID: 23724353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.
    Nicolini H; Bakish D; Duenas H; Spann M; Erickson J; Hallberg C; Ball S; Sagman D; Russell JM
    Psychol Med; 2009 Feb; 39(2):267-76. PubMed ID: 18485261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China.
    Wu WY; Wang G; Ball SG; Desaiah D; Ang QQ
    Chin Med J (Engl); 2011 Oct; 124(20):3260-8. PubMed ID: 22088518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulated Gastric Acid Promotes the Horizontal Transfer of Multidrug Resistance Genes across Bacteria in the Gastrointestinal Tract at Elevated pH Levels.
    Wu HY; Wei ZL; Shi DY; Li HB; Li XM; Yang D; Zhou SQ; Peng XX; Yang ZW; Yin J; Chen TJ; Li JW; Jin M
    Microbiol Spectr; 2023 Jun; 11(3):e0482022. PubMed ID: 37070984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycerosomal thermosensitive in situ gel of duloxetine HCl as a novel nanoplatform for rectal delivery: in vitro optimization and in vivo appraisal.
    Salem HF; Ali AA; Rabea YK; El-Ela FIA; Khallaf RA
    Drug Deliv Transl Res; 2022 Dec; 12(12):3083-3103. PubMed ID: 35622235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Real-World, Prospective, Multicenter, Single-Arm Observational Study of Duloxetine in Patients With Major Depressive Disorder or Generalized Anxiety Disorder.
    Szekeres G; Rozsa S; Dome P; Barsony G; Gonda X
    Front Psychiatry; 2021; 12():689143. PubMed ID: 34220591
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials.
    Kong W; Deng H; Wan J; Zhou Y; Zhou Y; Song B; Wang X
    Front Pharmacol; 2020; 11():580858. PubMed ID: 33343351
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.
    Gomez AF; Barthel AL; Hofmann SG
    Expert Opin Pharmacother; 2018 Jun; 19(8):883-894. PubMed ID: 29806492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis.
    Li X; Zhu L; Zhou C; Liu J; Du H; Wang C; Fang S
    PLoS One; 2018; 13(3):e0194501. PubMed ID: 29558528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The noradrenergic paradox: implications in the management of depression and anxiety.
    Montoya A; Bruins R; Katzman MA; Blier P
    Neuropsychiatr Dis Treat; 2016; 12():541-57. PubMed ID: 27042068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials.
    Maneeton N; Maneeton B; Woottiluk P; Likhitsathian S; Suttajit S; Boonyanaruthee V; Srisurapanont M
    Drug Des Devel Ther; 2016; 10():259-76. PubMed ID: 26834458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis.
    Terrill AL; Hartoonian N; Beier M; Salem R; Alschuler K
    Int J MS Care; 2015; 17(2):49-56. PubMed ID: 25892974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, placebo-controlled, fixed-dose phase III study of vilazodone in patients with generalized anxiety disorder.
    Gommoll C; Durgam S; Mathews M; Forero G; Nunez R; Tang X; Thase ME
    Depress Anxiety; 2015 Jun; 32(6):451-9. PubMed ID: 25891440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients.
    Lipkovich IA; Choy EH; Van Wambeke P; Deberdt W; Sagman D
    BMC Musculoskelet Disord; 2014 Dec; 15():450. PubMed ID: 25532971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of medication on health-related quality of life in patients with generalized anxiety disorder.
    Wilson H; Mannix S; Oko-osi H; Revicki DA
    CNS Drugs; 2015 Jan; 29(1):29-40. PubMed ID: 25516469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcranial bright light treatment via the ear canals in seasonal affective disorder: a randomized, double-blind dose-response study.
    Jurvelin H; Takala T; Nissilä J; Timonen M; Rüger M; Jokelainen J; Räsänen P
    BMC Psychiatry; 2014 Oct; 14():288. PubMed ID: 25330838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.
    Katzman MA; Bleau P; Blier P; Chokka P; Kjernisted K; Van Ameringen M; ; Antony MM; Bouchard S; Brunet A; Flament M; Grigoriadis S; Mendlowitz S; O'Connor K; Rabheru K; Richter PM; Robichaud M; Walker JR
    BMC Psychiatry; 2014; 14 Suppl 1(Suppl 1):S1. PubMed ID: 25081580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial.
    Alaka KJ; Noble W; Montejo A; Dueñas H; Munshi A; Strawn JR; Lenox-Smith A; Ahl J; Bidzan L; Dorn B; Ball S
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):978-86. PubMed ID: 24644106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.